JA
Jack Allen Baird Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
7
Avg Return
Past Year
Past Year
35%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
42.9%
Neutral
57.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Downgraded
| $115 |
0%
downside
| 1 | +0.45% |
–
| 23 Feb ‘26 2 months ago |
|
|
|
Neutral
Maintained
| $44 |
10%
downside
| 1 | – |
–
| 11 Nov ‘25 5 months ago |
|
|
|
Outperform
Upgraded
| $64 |
363%
upside
| 2 | -55% |
0
%
| 15 Oct ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $12 |
88%
upside
| 1 | +43% |
0
%
| 2 Oct ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $4 |
201%
upside
| 1 | – |
–
| 14 May ‘25 11 months ago |
|
|
|
Outperform
Maintained
| $9 |
290%
upside
| 1 | +118% |
0
%
| 14 May ‘25 11 months ago |
|